Navigation Links
Johnson & Johnson (China) Investment Ltd. Acquires Guangzhou Bioseal Biotechnology Co., Ltd.
Date:5/3/2012

GUANGZHOU, China, May 3, 2012 /PRNewswire-Asia/ -- Johnson & Johnson (China) Investment Ltd. today announced it has acquired Guangzhou Bioseal Biotechnology Co., Ltd. (Bioseal) a privately held biopharmaceutical company specializing in the design, development and commercialization of a porcine plasma-derived biologic product for controlling bleeding during surgery. The acquisition was completed after obtaining all necessary Chinese Government approvals. Financial terms of the transaction are not being disclosed.

"This transaction reinforces our commitment to China and delivering innovative medical device solutions to the Chinese market," said Xie Wen Jian President of Johnson & Johnson Medical China. "We are very pleased to add the BIOSEAL™ brand to our growing portfolio of hemostasis products in China and we look forward to working with our new Bioseal colleagues to bring their innovative products to more physicians and patients."

Bioseal manufactures a porcine-derived fibrin sealant, BIOSEAL™, currently the only porcine plasma-derived fibrin sealant approved for use in China. Fibrin sealants are used by surgeons as an adjunct to hemostasis for use in patients undergoing surgery, when control of bleeding by standard surgical techniques is ineffective or impractical.

Bioseal will work closely with Ethicon, Inc., a Johnson & Johnson Company, which offers the world's most complete line of absorbable hemostats with a commitment to advancing the future of biosurgery beyond hemostasis, to seal leaks, join structures and enhance healing. Ethicon biosurgery brands already on the market in China include SURGICEL® and SURGIFLO®.

"By adding Bioseal to the existing line of Ethicon hemostasis products sold in China, we aspire to shape the broader biosurgery market in Asia by providing physicians and their patients with an even greater variety of innovative and clinical-based solutions to add
'/>"/>

SOURCE Johnson & Johnson (China) Investment Ltd.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Johnson & Johnson to Provide Webcast Presentation of XARELTO® (rivaroxaban) Phase 3 Clinical Data Presented at the American College of Cardiologys Annual Scientific Sessions
2. CNJ Enterprises: DePuy ASR Hip Implant Recall Large Contributor to Johnson & Johnsons $2.9 Bil Charge for 4th Quarter 2011
3. Johnson & Johnson Reports 2011 Fourth-Quarter and Full-Year Results:
4. Johnson & Johnson to Host Analyst Meeting to Discuss Fourth-Quarter and Full-Year 2011 Financial Results
5. Johnson & Johnson to Participate in the Piper Jaffray 23rd Annual Health Care Conference
6. Johnson & Johnson Reports 2011 Third-Quarter Results
7. Johnson & Johnson to Host Analyst Conference Call on Third-Quarter Results
8. Boston Scientific Announces Favorable Appellate Court Ruling Affirming Non-Infringement of Johnson & Johnson Patent
9. McNEIL-PPC, Inc. Acquires Full Ownership of the Johnson & Johnson-Merck Consumer Pharmaceuticals Co. Joint Venture
10. Johnson & Johnson Makes Strong Progress in First Year of Initiative to Improve Health of Millions of Women and Children in the Developing World
11. Johnson & Johnson to Participate in Morgan Stanley Global Health Care Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/19/2014)... , Aug. 19, 2014  Cardiva Medical, Inc. ... tranches of a $16.5 million Series 3 private equity ... GE Capital. The Company will use the proceeds of ... to expand commercial efforts for its VASCADE® Vascular Closure ... Investing in Series 3 private equity ...
(Date:8/19/2014)... , August 19, 2014 ... a clinical-stage pharmaceutical company focused on the development ... the Intellectual Property Department of Spain ... its invention, titled "Methods and Compositions for Oral ... Oramed Pharmaceuticals is a technology pioneer ...
(Date:8/19/2014)... MENLO PARK, Calif. , Aug. 19, 2014 /PRNewswire/ ... announced today a protocol amendment to allow for expanded dosing ... U.S. Food and Drug Administration (FDA) and that a new ... at three clinical trial sites in the United ... of US$2.9 million have been raised through warrant exercise in ...
Breaking Medicine Technology:Cardiva Medical, Inc. Announces Completion of the first two tranches of Series 3 Private Equity Financing and the Closing of a Senior Secured Debt Facility with GE Capital 2Oramed Granted Patent in Spain for Oral Administration of Insulin 2Oramed Granted Patent in Spain for Oral Administration of Insulin 3DelMar Pharmaceuticals Provides Update on Glioblastoma Clinical Trial and Results of Warrant Tender Offer 2DelMar Pharmaceuticals Provides Update on Glioblastoma Clinical Trial and Results of Warrant Tender Offer 3DelMar Pharmaceuticals Provides Update on Glioblastoma Clinical Trial and Results of Warrant Tender Offer 4DelMar Pharmaceuticals Provides Update on Glioblastoma Clinical Trial and Results of Warrant Tender Offer 5DelMar Pharmaceuticals Provides Update on Glioblastoma Clinical Trial and Results of Warrant Tender Offer 6DelMar Pharmaceuticals Provides Update on Glioblastoma Clinical Trial and Results of Warrant Tender Offer 7
... R.I., May 19, 2011 CVS Caremark Corporation (NYSE: ... President and Chief Executive Officer, will be making a ... Global Consumer Conference on May 25, 2011. Mr. Merlo ... (Logo: http://photos.prnewswire.com/prnh/20090226/NE75914LOGO) An audio webcast of ...
... 2011 Two studies published in Digestive ... for performing the standard upper endoscopy examination done on over ... of pre-cancerous cells in the esophagus by over 40 percent. ... 25 years, making it the fastest growing form of cancer ...
Cached Medicine Technology:Improved Endoscopy Method Increases Detection of Esophageal Pre-Cancer by Over 40 Percent 2Improved Endoscopy Method Increases Detection of Esophageal Pre-Cancer by Over 40 Percent 3Improved Endoscopy Method Increases Detection of Esophageal Pre-Cancer by Over 40 Percent 4
(Date:8/20/2014)... Kowa Optimed returns after a short hiatus to ... SL-17 portable slit lamp. , The SL-17 has been ... by an illuminated thumb wheel for easy adjustments even ... AAA rechargeable and dry cell batteries, which is an ... specifically for the device. The new Sl-17 base design ...
(Date:8/20/2014)... (PRWEB) August 20, 2014 Riverside Health ... Dameron , who joined its Warsaw Medical Arts team ... specialized in Family Medicine, is accepting new patients. , ... of Medicine, completed his residency at the Mountain Area ... to Virginia. , “I really like the rural aspect ...
(Date:8/20/2014)... 20, 2014 This agreement will ... software defined networking, high availability cloud enablement, service, ... Resellers, while allowing OPEN-V to sell storageFOUNDRY’s expanding ... to work with OPEN-V on this distribution agreement ... manager distribution channels at storageFOUNDRY. "Nautilus is a ...
(Date:8/19/2014)... As moms and dads prepare their children to go back ... routine of dropping their little ones off at daycare with ... encourages them to use the opportunity to implement a new ... explains, “Kids have small tummies, short attention spans, and a ... handouts, use snack time as another daily opportunity to incorporate ...
(Date:8/19/2014)... (PRWEB) August 20, 2014 Midtown Dentistry in ... amalgam-free dental office. All patients with cavities, or with ... latest white fillings that can safely repair and restore teeth. ... the very latest materials, all of which are completely amalgam ... safe for use by the FDA for adults and children ...
Breaking Medicine News(10 mins):Health News:Kowa Optimed (Booth MS13043) to Debut New Portable Slit Lamp at 2014 Vision Expo West in Las Vegas, Nevada 2Health News:Riverside Warsaw Medical Arts’ Dr. William Dameron Accepting New Patients 2Health News:storageFOUNDRY and Open-V OzoneStack Announce Bilateral Distribution Agreement 2Health News:storageFOUNDRY and Open-V OzoneStack Announce Bilateral Distribution Agreement 3Health News:Child Nutritionist Kristen Yarker Wants Parents to Rethink Kids’ Snacks This Fall 2Health News:Child Nutritionist Kristen Yarker Wants Parents to Rethink Kids’ Snacks This Fall 3Health News:Midtown Dentistry Announces It Is Now an Amalgam-Free Office 2
... ... Save Lives in Healthcare Facilities and for Senior Care at Home. , ... (PRWEB) January 26, 2010 -- New inexpensive technologies ... effect of falls particularly in the population now approaching 60 and above. New personal use ...
... ... Cancer Care Delivery System , ... Washington, DC (Vocus) January 26, 2010 -- Community oncologists nationwide, under the ... urge President Obama and lawmakers to reverse drastic cuts in reimbursement for cancer care ...
... , Jan. 26 Milliman Care Guidelines LLC, ... that help health plans, hospitals and other clients optimize the ... software.   , The Care Guidelines promote quality ... on annually updated evidence, thus enabling informed and consistent clinical ...
... ... launched three new document scanners with rated speeds up to 60 images per minute ... models include a 2-Year manufacturer’s warranty, BulletScan Manager Software, and ABBYY FineReader® ... ...
... ... they are now offering Trek’s Ride+ electric assist bikes to their guests. By being one of ... opening up a new world of cycling vacations to a wider range of riders. Now anyone ... ...
... OAK BROOK, Ill. Preoperative computed tomography (CT) may ... with suspected acute appendicitis, according to a new study ... Radiology . "We found that rising utilization of ... in CT technology, coincided with a significant decrease in ...
Cached Medicine News:Health News:Medical Nurse Training, Inc and SaferFalls.com Announce New Products/Technologies to Save Lives in Healthcare Facilities and for Senior Home Care. 2Health News:Medical Nurse Training, Inc and SaferFalls.com Announce New Products/Technologies to Save Lives in Healthcare Facilities and for Senior Home Care. 3Health News:Community Oncologists Launch Petition to Stop Drastic Cancer Care Cuts 2Health News:Community Oncologists Launch Petition to Stop Drastic Cancer Care Cuts 3Health News:Milliman Care Guidelines Offers Online Interrater Reliability Tool and Training 2Health News:Milliman Care Guidelines Offers Online Interrater Reliability Tool and Training 3Health News:Milliman Care Guidelines Offers Online Interrater Reliability Tool and Training 4Health News:iVina Expands BulletScan Document Scanner Product Line Powered by ABBYY FineReader Technology 2Health News:iVina Expands BulletScan Document Scanner Product Line Powered by ABBYY FineReader Technology 3Health News:iVina Expands BulletScan Document Scanner Product Line Powered by ABBYY FineReader Technology 4Health News:Trek Travel Introduces Trek's Ride+ Electric Assist Bikes to Cycling Vacations 2Health News:Preoperative CT useful for younger women with suspected appendicitis 2
... to the National Academy of ... use of cardiac markers in ... is definitive of acute myocardial ... assay was designed for rapid ...
A fluorogenic enzyme-linked immunoassay (ELISA) for the quantitative measurement of myoglobin in human serum or plasma aiding in the diagnosis of acute myocardial infarction (AMI). Features : Dry che...
Clinical marker immunoassay kit for detection of Myoglobin....
AxSYM Myoglobin is a Microparticle Enzyme Immunoassay (MEIA) for the quantitative determination of myoglobin in human serum or plasma on the AxSYM System....
Medicine Products: